J10 MAC B
Effective October 1, 2012, the Cahaba GBA Local Coverage Article for Drugs & Biologicals – Chemotherapeutic Agents (A48896) is being updated.
In accordance with the NCCN Drugs & Biologics Compendium®, the list of payable ICD-9 diagnosis codes for Paclitaxel Protein-Bound Particles (Abraxane®) (J9264) is expanded to include 158.8-158.9, 183.0, 183.2-183.5, 183.8-183.9, and V10.43 for the off-label use in ovarian cancer – epithelial ovarian cancer/fallopian tube cancer/primary peritoneal cancer.
This Article can be accessed from the Local Coverage Determinations (LCDs) and Articles page of our website (choose your state and select ‘Articles’).